Adjuvant Systemic Therapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group’s Trials of Cyclophosphamide or CMF in Premenopausal and Tamoxifen in Postmenopausal Patients
- 1 January 1984
- book chapter
- Published by Springer Nature
- Vol. 96, 117-128
- https://doi.org/10.1007/978-3-642-82357-2_14
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Adjuvant systemic therapy in breast cancer; a reviewEuropean Journal of Cancer and Clinical Oncology, 1983
- Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.BMJ, 1983
- Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancerBreast Cancer Research and Treatment, 1983
- Antiestrogen treatment of postmenopausal women with primary high risk breast cancerBreast Cancer Research and Treatment, 1983
- Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer InstitutePublished by Elsevier ,1980
- Total Mastectomy and Partial Axillary DissectionSurgical Clinics of North America, 1973